John S. Ross
President, Mayne Pharma USA
Mr. Ross has more than 20 years’ experience in the pharmaceutical industry across marketing and sales, manufacturing and distribution, global sourcing and supply chain. Prior to joining Mayne Pharma, Mr. Ross was a Principal at Tunnell Consulting a leading US biotech and pharmaceutical consulting organization. He has also held a number of leadership roles including Chief Operating Officer of Contract Pharmaceuticals Limited, a provider of outsourced third-party contract development, manufacturing and testing of pharmaceuticals.
Executive Vice President, Metrics Contract Services
Ms. McClintock has more than 18 years of experience in the pharmaceutical industry across sales, business development, project management and research and development. Prior to joining Mayne Pharma, Kim led the Drug Product and Lab Services Business Unit as Senior Director at Alcami Corp, a leading global provider of contract development and manufacturing services. She also held several management roles at Banner Pharmacaps (division of Patheon). Ms. McClintock holds a Bachelor of Arts in Chemistry from North Carolina State University and a MBA from the University of North Carolina at Greensboro.
Vice President and General Manager of Greenville Operations
Mr. Childers directs, manages and improves site operations for all of Mayne Pharma’s facilities in Greenville, N.C. A Six Sigma Black Belt, Mr. Childers is responsible for the day-to-day management of functions including environmental health and safety, quality control, engineering, maintenance and security, ensuring that operations comply with global regulatory and pharmaceutical industry standards. He holds a master’s degree in organic chemistry from the Stevens Institute of Technology and a bachelor’s degree in clinical chemistry from West Chester University.
Thomas B. "Brad" Gold, PhD
Vice President, Pharmaceutical Development
As vice president of pharmaceutical development, Dr. Gold is responsible for overseeing all personnel, facilities and services related to formulation development, potent and cytotoxic products, fast-track development, and analytical methods development and validation. In addition, Dr. Gold is responsible for implementing new technology platforms that include advanced drug delivery methods. He holds a doctorate in pharmaceutics/medicinal chemistry from the University of Kentucky, from which he earned master’s and bachelor’s degrees in chemistry.
Vice President, Analytical Services
As vice president of analytical services, Mr. Moore is responsible for the day-to-day leadership of the company’s analytical services team, comprising some 100 chemists. The division helps clients determine and ensure the identity, purity, potency and performance of drug products by conducting analytical chemistry and microbiology tests, method development and validation, and stability studies in compliance with international standards. Mr. Moore joined Metrics Contract Services in 1998 as a laboratory analyst and consistently took on roles of increasing responsibility to become senior manager of analytical services by 2012. Prior to his current appointment, he served as senior manager of technical operations at Salix Pharmaceuticals, where he managed R&D and commercial activities at numerous contract organizations.
Vice President, Quality
As vice president of quality for Mayne Pharma U.S., Mr. Lewis is responsible for managing all quality-related functions to ensure that Mayne Pharma’s U.S. pharmaceutical operations – which range from laboratories to manufacturing lines utilized – continue to comply with regulatory agency and industry standards. The Mayne Pharma U.S. quality unit provides quality support and compliance oversight for the Metrics Contract Services unit.
Mr. Lewis brings more than 30 years of pharmaceutical industry experience to his role. Before joining Mayne Pharma, he was senior director of quality for Teva Pharmaceuticals, where he managed quality assurance and quality control functions for a large solid dose manufacturing site. Prior to that, he served as vice president of corporate quality for IRIX Pharmaceuticals, and as director of quality operations for DSM Pharmaceuticals.
Having joined Mayne Pharma in 2014, Mr. Lewis holds a bachelor’s degree in chemistry from the University of North Carolina – Chapel Hill.
Vice President, Manufacturing Science and Technology
Mr. Cascone oversees the means by which products are transitioned from development to commercial manufacture and transfers between sites are completed, as well as the manufacture of on-market products meet evolving business needs. He evaluates the technical merits of new portfolio opportunities and serves on the senior leadership team. Mr. Cascone holds a bachelor’s of science degree from Virginia Tech and a master’s degree in business administration from East Carolina University.